Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.72 USD | +1.98% | -2.89% | +56.91% |
14/05 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
30/04 | North American Morning Briefing : More Earnings -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.91% | 24Cr | |
+43.36% | 5.46TCr | |
-5.31% | 3.99TCr | |
+37.52% | 3.88TCr | |
+14.75% | 2.69TCr | |
-12.56% | 2.62TCr | |
-22.45% | 1.88TCr | |
+25.12% | 1.22TCr | |
+0.04% | 1.22TCr | |
+26.04% | 1.19TCr |
- Stock Market
- Equities
- ACRV Stock
- News Acrivon Therapeutics, Inc.
- Acrivon Therapeutics Names Jean-Marie Cuillerot as Chief Medical Officer